Results 161 to 170 of about 9,262,118 (306)

Miscellaneous sketchbook, 2 [picture] /

, 1930
Title devised by cataloguer from acquisitions documentation.; Part of the John Power sketchbooks collection.; Condition: Yellowing, soiled, stained, tears.; Also available online at: http://nla.gov.au/nla.pic-vn6293848; Exhibited: Abstraction-Creation: J.
Power, J. J. W. (John Joseph Wardell), 1881-1943.
core  

Evaluating multi-ancestry genome-wide association methods: Statistical power, population structure, and practical implications. [PDF]

Am J Hum Genet
Dias JA, Chen T, Xing H, Wang X, Rodriguez AA, Madduri RK, Kraft P, Zhang H.   +7 more
europepmc   +2 more sources

Effect Sizes and Statistical Power in Hearing Aid Research. [PDF]

Am J Audiol
Pandey P, Graham M, Sharma A, Swanepoel W, Manchaiah V.   +4 more
europepmc   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Norfolk sketchbook [picture] /

, 1930
Title devised by cataloguer.; Part of the John Power sketchbooks collection.; Inscriptions: "Norfolk"--In pencil on front cover.; Condition: Yellowing, soiled, stained.; Also available online at: http://nla.gov.au/nla.pic-vn6292751; Exhibited ...
Power, J. J. W. (John Joseph Wardell), 1881-1943.
core  

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran, Malo Gaubert, Alice Dufey, Elise Bannier, Audrey Rico, Jean‐Christophe Ferré, Raphaël Chouteau, Laure Michel, Emmanuelle Le Page, Virginie Callot, Bertrand Audoin, Sarah Demortière, Benoît Combès, Anne Kerbrat   +13 more
wiley   +1 more source

Additional crossovers in cluster randomised crossover trials do not always increase statistical power. [PDF]

Clin Trials
Tanvir KM, Forbes AB, Grantham KL, Kasza J.   +3 more
europepmc   +1 more source

Clinical Impact of NOTCH3 Variant Location After First Stroke in CADASIL

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite its monogenic origin, Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy exhibits marked variability in clinical expression and severity. Variants in the NOTCH3 gene, within epidermal growth factor‐like repeat domains 1–6 or 7–34, are known to influence disease onset, but their impact ...
Léa Aguilhon, Hugues Chabriat, Dominique Hervé, Stéphanie Guey, Sophie Tezenas Du Montcel, Juliette Ortholand   +5 more
wiley   +1 more source

How to improve statistical power in a trial with SCA2 patients using natural history data. [PDF]

Trials
Tran M, Poulet PE, Petit E, Durr A, Klockgether T, Ashizawa T, Coarelli G, du Montcel ST.   +7 more
europepmc   +1 more source

Unraveling 4‐Phenylbutyrate's Therapeutic Role in SLC6A1 Disorders: Pharmacochaperoning Over HDAC Inhibition

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Variants in SLC6A1, encoding the GABA transporter 1 (GAT‐1), cause epilepsy, autism spectrum disorder, and developmental delay via loss of GABA uptake, impaired trafficking, and ER retention. We previously found that 4‐Phenylbutyrate (PBA), an FDA‐approved drug, restores GABA uptake and reduces seizures in SLC6A1‐related disorders ...
Melissa B. DeLeeuw, Karishma Randhave, Ekta Anand, Ziang (Debbie) Song, Wangzhen Shen, Jing‐Qiong Kang   +5 more
wiley   +1 more source